ClinicalTrials.govpublic full text
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
ependymoma, glioblastoma, medulloblastoma, recurrent metastatic malignant neoplasm in the leptomeninges, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 851887
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.